Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed6
Recruiting1

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT03884075Phase 2Recruiting
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Steatohepatitis
PrincipalinvestigatorStart date: 2019-07-24
NCT02520609Completed
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Fatty LiverLiver Disease
PrincipalinvestigatorStart date: 2015-10-28
NCT01792115Phase 2Completed
Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Fatty Liver
PrincipalinvestigatorStart date: 2013-05-01
NCT00659256Completed
Hepatitis C Treatment and Atherosclerosis
AtherosclerosisChronic Hepatitis C
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen A. Harrison, MD

Brooke Army Medical Center

Related
16 trials

Shared therapeutic areas:

Nonalcoholic SteatohepatitisFatty LiverHepatitis C, Chronic+1 more
Similarity Score20%

Marc G Ghany, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
14 trials

Shared therapeutic areas:

Hepatitis C, ChronicNon-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Fatty LiverLiver Diseases
Similarity Score10%

Sonia Caprio, MD

Yale University

Related
9 trials

Shared therapeutic areas:

Fatty LiverNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score10%

Michael Roden, Prof., MD

German Diabetes Center

Related
16 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Similarity Score10%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score5%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

Liver Diseases
Similarity Score5%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Fatty Liver
Similarity Score5%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Atherosclerosis
Similarity Score5%

Shih-Jer Hsu, MD

National Taiwan University Hospital, Yun-Lin Branch

Related
5 trials

Shared therapeutic areas:

Hepatitis C, Chronic
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT03884075Phase 2PrincipalInvestigator

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Steatohepatitis
Recruiting
NCT02520609PrincipalInvestigator

Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease

Fatty LiverLiver Disease
Completed
NCT02363309PrincipalInvestigator

Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)

Fatty Liver
Completed
NCT01792115Phase 2PrincipalInvestigator

Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E

Fatty Liver
Completed
NCT00659256PrincipalInvestigator

Hepatitis C Treatment and Atherosclerosis

AtherosclerosisChronic Hepatitis C
Completed
NCT00718172Phase 1PrincipalInvestigator

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Hepatitis C, Chronic
Completed
NCT01867385PrincipalInvestigator

The Physiology of Fatigue in Patients With Chronic Liver Disease

Liver Disease
Completed

All 7 trials loaded